Manuel Dominguez
Advertisement
Articles by Manuel Dominguez
87 Elacestrant Plus Abemaciclib Combination in Patients With Estrogen Receptor-positive, HER2-Negative Advanced or Metastatic Breast Cancer
ByHope S. Rugo, MD,Sara M. Tolaney, MD, MPH,Nancy Chan,Erika P. Hamilton, MD,Eva Ciruelos,Ji-Yeon Kim,Elena López-Miranda,Elia Seguí,Neelima Vidula, MD,Joyce O’Shaughnessy, MD,Guiseppe Curigliano,Javier Cortés, MD,Alessandro Di Sanzo,Paula Muñoz Romero,Bartomeu Piza Vallespir,Manuel Dominguez,Kathy Puyana Theall,Alessandro Paoli,Monica Binaschi,Tomer Wasserman,Virginia Kaklamani, MD, DSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Sacituzumab Govitecan Combo Reduces Progression, Death By 35% in Metastatic TNBC
2
Relacorilant/Nab-Paclitaxel Meets OS End Point in Platinum-Resistant Ovarian Cancer
3
BNT113 Granted Fast Track Designation in HPV16-Positive HNSCC
4
FDA Receives IND for First Registration Trial of FG001 in High-Grade Glioma
5